Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
2006 1
2008 3
2009 80
2010 208
2011 223
2012 198
2013 217
2014 225
2015 229
2016 252
2017 227
2018 250
2019 232
2020 242
2021 220
2022 175
2023 126
2024 55

Text availability

Article attribute

Article type

Publication date

Search Results

2,664 results

Results by year

Filters applied: . Clear all
Page 1
Prenatal Enzyme-Replacement Therapy.
van der Ploeg AT. van der Ploeg AT. N Engl J Med. 2022 Dec 8;387(23):2189-2193. doi: 10.1056/NEJMe2211515. Epub 2022 Nov 9. N Engl J Med. 2022. PMID: 36351269 No abstract available.
Update of treatment for Gaucher disease.
Kong W, Lu C, Ding Y, Meng Y. Kong W, et al. Eur J Pharmacol. 2022 Jul 5;926:175023. doi: 10.1016/j.ejphar.2022.175023. Epub 2022 May 13. Eur J Pharmacol. 2022. PMID: 35569551 Review.
[Mucopolysaccharidosis: clinical features, diagnosis and management].
Suarez-Guerrero JL, Gómez Higuera PJ, Arias Flórez JS, Contreras-García GA. Suarez-Guerrero JL, et al. Rev Chil Pediatr. 2016 Jul-Aug;87(4):295-304. doi: 10.1016/j.rchipe.2015.10.004. Epub 2015 Nov 21. Rev Chil Pediatr. 2016. PMID: 26613630 Free article. Review. Spanish.
Enzyme replacement therapy.
Moore A. Moore A. Surv Ophthalmol. 2019 May-Jun;64(3):439. doi: 10.1016/j.survophthal.2018.09.003. Epub 2018 Oct 2. Surv Ophthalmol. 2019. PMID: 30287261 No abstract available.
State of the Art in Exocrine Pancreatic Insufficiency.
Diéguez-Castillo C, Jiménez-Luna C, Prados J, Martín-Ruiz JL, Caba O. Diéguez-Castillo C, et al. Medicina (Kaunas). 2020 Oct 7;56(10):523. doi: 10.3390/medicina56100523. Medicina (Kaunas). 2020. PMID: 33036352 Free PMC article. Review.
A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results.
Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Gallagher RC, Giugliani R, Guelbert NB, Ikezoe T, Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Villarrubia J, Chen Y, Furey S, Thurberg BL, Zaher A, Kumar M. Wasserstein M, et al. Genet Med. 2022 Jul;24(7):1425-1436. doi: 10.1016/j.gim.2022.03.021. Epub 2022 Apr 26. Genet Med. 2022. PMID: 35471153 Free article. Clinical Trial.
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review.
Palaiodimou L, Kokotis P, Zompola C, Papagiannopoulou G, Bakola E, Papadopoulou M, Zouvelou V, Petras D, Vlachopoulos C, Tsivgoulis G. Palaiodimou L, et al. Curr Neuropharmacol. 2023;21(3):440-456. doi: 10.2174/1570159X20666220601124117. Curr Neuropharmacol. 2023. PMID: 35652398 Free PMC article. Review.
European expert consensus statement on therapeutic goals in Fabry disease.
Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ. Wanner C, et al. Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. Mol Genet Metab. 2018. PMID: 30017653 Review.
Enzyme replacement therapy for infantile-onset Pompe disease.
Chen M, Zhang L, Quan S. Chen M, et al. Cochrane Database Syst Rev. 2017 Nov 20;11(11):CD011539. doi: 10.1002/14651858.CD011539.pub2. Cochrane Database Syst Rev. 2017. PMID: 29155436 Free PMC article. Review.
2,664 results